Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: The EPIPHANY study

European Respiratory Journal

Volumn 49, Issue 1, 2017, Pages

  Font, Carme ^a   Carmona Bayonas, Alberto ^b   Beato, Carmen ^c   Reig, Òscar ^a   Sáez, Antonia ^d   Jiménez Fonseca, Paula ^e   Plasencia, Juana M ^b   Calvo Temprano, David ^e   Sanchez, Marcelo ^a   Benegas, Mariana ^a   Biosca, Mercedes ^f   Varona, Diego ^f   Vicente, Maria Angeles ^b   Faez, Laura ^e   Del Pilar Solís, Maria ^e   De La Haba, Irma ^g   Antonio, Maite ^g   Madridano, Olga ^h   Castañon, Eduardo ⁱ   Martinez, María Jose ^j   Marchena, Pablo ^k   Ramchandani, Avinash ^l   Dominguez, Angel ^c   Puerta, Alejandro ^m   De La Haza, David Martinez ^g   Pueyo, Jesus ⁱ   Hernandez, Susana ^h   Fernandez Plaza, Angela ^j   Martinez Encarnacion, Lourdes ^j   Martin, Mar ^h   Marin, Gema ⁿ   Ayala, Francisco ^b   Vicente, Vicente ^b   Otero, Remedios ^o   more..

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

^c Hospital Nisa Aljarafe   (Spain)

^d Statistical Dept   (Spain)

^e Hospital Universitario   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

ⁱ UNIVERSITY CLINIC OF NAVARRA   (Spain)

^j Hospital Santa Lucia   (Spain)

^k HOSPITAL SANT JOAN DE DÉU   (Spain)

^l HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^m HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^o HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CISPLATIN; ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLEEDING; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CHRONIC LUNG DISEASE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DYSPNEA; FAINTNESS; FEMALE; FEMALE GENITAL TRACT CANCER; HEART RATE; HEMOPTYSIS; HUMAN; HYPOTENSION; INCIDENTAL FINDING; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; METASTASIS; MORTALITY RATE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; SYMPTOMATOLOGY; THORAX PAIN; UNSUSPECTED PULMONARY EMBOLISM; URINARY TRACT CANCER; VENOUS THROMBOEMBOLISM; VERY ELDERLY; ADOLESCENT; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; RISK FACTOR; SPAIN; STATISTICAL MODEL; TIME FACTOR; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEMORRHAGE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 85008500826     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00282-2016     Document Type: Article

References (39)

1. Sørensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-1850.
2. Carson JL, Kelley MA, Duff M, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326:1240-1245.
3. Laporte S, Mismetti P, Décousus H, et al. Clinical predictors for fatal pulmonary embolism in 15, 520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008;117:1711-1716.
4. Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: A risk score. Thromb Haemost 2000;84:548-552.
5. Donzé J, Le Gal G, Fine MJ, et al. Prospective validation of the pulmonary embolism severity index: a clinical prognostic model for pulmonary embolism. Thromb Haemost 2008;100:943-948.
6. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383-1389.
7. Kline JA, Roy PM, Than MP, et al. Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Thromb Res 2012; e194-e199.
8. Den Exter PL, Gómez V, Jiménez D, et al. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. Chest 2013;143:138-145.
9. Carmona-Bayonas A, Font C, Jiménez-Fonseca P, et al. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism. Thromb Res 2016;143:76-85.
10. Dentali F, Ageno W, Becattini C, et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res 2010;125:518-522.
11. Sun JM, Kim TS, Lee J, et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy. Lung Cancer 2010;69:330-336.
12. Font C, Farrús B, Vidal L, et al. Incidental versus symptomatic venous thrombosis incancer patients. Analysis of a prospective observational series with 340 consecutive patients. Ann Oncol 2011;23:2101-2106.
13. Shinagare AB, Okajima Y, Oxnard GR, et al. Unsuspected pulmonary embolism inlung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer 2012;78:161-166.
14. van Es N, Bleker SM, Di Nisio M. Cancer-associated unsuspected pulmonary embolism. Thromb Res 2014;133:S172-S178.
15. den Exter PL, Kroft LJ, van del Hulle T, et al. Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast-enhanced computed tomography imaging in cancer patients. J Thromb Haemost 2013;11:1620-1622.
16. O'Connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost 2011;9:305-311.
17. den Exter PL, Hooijer J, Dekkers OM, et al. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2012;29:2405-2409.
18. Kearon C, Akl EA, Omelas J, et al. Antithrombotic therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016;149:315-352.
19. Konstantinides S, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033-3069.
20. Di Nisio M, Lee AY, Carrier M, et al. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2015;13:880-883.
21. Font C, Carmona-Bayonas A, Plasencia JM, et al. Pulmonary embolism in patients with cancer: foundations of the EPIPHANY study. Med Clin (Barc) 2015;144 Suppl 1:31-37.
22. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990;263:2753-2759.
23. Simel DL. Approach to the patient: history and physical examination. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 24th edn. Saunders Elsevier, Philadelphia, 2011; pp. 22-27.
24. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3:692-694.
25. Font C, Carmona-Bayonas A, Fernández-Martinez A, et al. Outpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients. J Natl Compr Canc Netw 2014;12:365-373.
26. Kuderer NM, Lyman GH. Guidelines for treatment and prevention of venous thromboembolism among patients with cancer. Thromb Res 2014;133 Suppl:S122-S127.
27. Oken, MM, Creech RH, Tormey DC, et al. Toxicity And response criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
28. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-216.
29. Becattini C, Cohen AT, Agnelli G, et al. Risk stratification of patients with acute symptomatic pulmonary embolism based on presence or absence of lower extremity deep vein thrombosis: systematic review and meta-analysis. Chest 2016;149:192-200.
30. Falanga A, Marchetti M, Russo L. The mechanisms of cancer-associated thrombosis. Thromb Res 2015;135:Suppl 1, S8-S11.
31. Tapson VF. Acute pulmonary embolism. N Engl J Med 2008;358:1037-1052.
32. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010;363:266-274.
33. Monreal M, Ruiz J, Fraile M, et al. Prospective study on the usefulness of lung scan in patients with deep vein thrombosis of the lower limbs. Thromb Haemost 2001;85:771-774.
34. O'Connell CL, Boswell WD, Duddalwar V, et al. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol 2006;24:4928-4932.
35. O'Connell CL, Razavi PA, Liebman HA. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. J Clin Oncol 2011;29:4208-4209.
36. Streiff M. Diagnosis and initial treatment of venous thromboembolism in patients with cancer. J Clin Oncol 2009;27:4889-4894.
37. Palmer J, Bozas G, Stephens A, et al. Developing a complex intervention for outpatient management of incidentally diagnosed pulmonary embolism in cancerpatients. BMC Health Serv Res 2013;13:235.
38. Van der Hulle T, den Exter P, Planquette B, et al. Risk of recurrent venous thromboembolism and major haemorrhage in cancer-associated incidental pulmonary embolism amongst treated and untreated patients: a pooled analysis of 926 patients. J Thromb Haemost 2016;14:105-113.
39. Zwicker JI, Bauer KA. How long is long enough? Extended anticoagulation for the treatment of cancer-associated deep vein thrombosis. J Clin Oncol 2014;32:3596-3599.